|
|
Declined 2012 Republican Presidential Candidate
Former Governor of Alaska
Sarah Palin
|
 |
|
Palin position on Prescription Drugs
|
• Sarah Palin is of the opinion that the market of prescription drugs is controlled to a great extent by Government regulations which should be relaxed and made more flexible. According to her, this would lead to the growth of competition in the sector which in turn would help to control prices of prescription drugs.
• Due to the heavy expenses incurred by families in buying medicines, Sarah Palin has proposed a tax credit for families so as to enable them to buy a suitable insurance plan of their choice which would cover all the related bills.
• Having let the prescription drug database law take effect in her state without her signature, Sarah Palin has expressed doubts with regards to the privacy of the program. Although she expressed support for the program, she claimed to have heard concerns voiced by healthcare providers that care may be denied by patients due to the privacy factor.
• Sarah Palin has been one of the front-line supporters for the prescription drug monitoring program which requires the pharmacies to register the prescriptions mentioning abuse-prone drugs.
• Sarah Palin is of the opinion that there should be more competition in this sector as it would not only lead to more choices but would also make medicines more affordable to common people. This would not only make the sector business driven but would also leave less room for litigation.
• Being a firm believer in nature, Sarah Palin is against the use of medicines in general as she holds the opinion that it is the individual who is responsible for his health and therefore everyone should take personal responsibility for their health by making responsible and healthy choices, thereby eliminating the need for pills.
|
All Presidential Candidates on Prescription Drugs
|
|
|
Support our website with Google Plus |
| Comment on Sarah Palin's position on Prescription Drugs |
|
|
Compare other 2012 candidates position on Prescription Drugs
|
|
